Journal of Clinical Oncology

Erratum: Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease

J Jack P. Gleeson A Andrea Knezevic (Memorial Sloan Kettering Cancer Center, New York, NY) M Maria Bromberg (1Memorial Sloan Kettering Cancer Center, New York, United States) S Sujata Patil J Joel Sheinfeld (Memorial Sloan Kettering Cancer Center, New York, NY) B Brett S. Carver M Manjit Bains D David R. Jones (MPA-Center for Integrated Nanotechnologies, Los Alamos National Laboratory 2 , Los Alamos, New Mexico 87545,) D Dean F. Bajorin (Memorial Sloan Kettering Cancer Center, New York, NY) G George J. Bosl D Deaglan J. McHugh S Samuel A. Funt (Memorial Sloan Kettering Cancer Center, New York, NY) R Robert J. Motzer (Memorial Sloan Kettering Cancer Center, New York) D Darren R. Feldman (Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 12
Published April 20, 2025
Pages 1521-1521
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (14)

J

Jack P. Gleeson

A

Andrea Knezevic

Memorial Sloan Kettering Cancer Center, New York, NY

M

Maria Bromberg

1Memorial Sloan Kettering Cancer Center, New York, United States

S

Sujata Patil

J

Joel Sheinfeld

Memorial Sloan Kettering Cancer Center, New York, NY

B

Brett S. Carver

M

Manjit Bains

D

David R. Jones

MPA-Center for Integrated Nanotechnologies, Los Alamos National Laboratory 2 , Los Alamos, New Mexico 87545,

D

Dean F. Bajorin

Memorial Sloan Kettering Cancer Center, New York, NY

G

George J. Bosl

D

Deaglan J. McHugh

S

Samuel A. Funt

Memorial Sloan Kettering Cancer Center, New York, NY

R

Robert J. Motzer

Memorial Sloan Kettering Cancer Center, New York

D

Darren R. Feldman

Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001